We have recently identified apoptosis-antagonizing transcription factor (AATF), tumor-susceptibility gene 101 (TSG101) and zipperinteracting protein kinase (ZIPK) as novel coactivators of the androgen receptor (AR). The mechanisms of coactivation remained obscure, however. Here we investigated the interplay and interdependence between these coactivators and the AR using the endogenous prostate specific antigen (PSA) gene as model for AR-target genes. Chromatin immunoprecipitation in combination with siRNA-mediated knockdown revealed that recruitment of AATF and ZIPK to the PSA enhancer was dependent on AR, whereas recruitment of TSG101 was dependent on AATF. Association of AR and its coactivators with the PSA enhancer or promoter occurred in cycles. Dissociation of AR-transcription complexes was due to degradation because inhibition of the proteasome system by MG132 caused accumulation of AR at enhancer/promoter elements. Moreover, inhibition of degradation strongly reduced transcription, indicating that continued and efficient transcription is based on initiation, degradation and reinitiation cycles. Interestingly, knockdown of ZIPK by siRNA had a similar effect as MG132, leading to reduced transcription but enhanced accumulation of AR at androgen-response elements. In addition, knockdown of ZIPK, as well as overexpression of a dominantnegative ZIPK mutant, diminished polyubiquitination of AR. Furthermore, ZIPK cooperated with the E3 ligase Mdm2 in AR-dependent transactivation, assembled into a single complex on chromatin and phosphorylated Mdm2 in vitro. These results suggest that ZIPK has a crucial role in regulation of ubiquitination and degradation of the AR, and hence promoter clearance and efficient transcription. 
INTRODUCTION
The androgen receptor (AR) is a ligand-dependent transcription factor, which is involved in differentiation, proliferation and homeostasis of male reproductive organs and has a critical role in development of prostate cancer. Upon hormone binding, the receptor dimerizes, translocates to the nucleus and binds to specific DNA sequences termed androgen-response elements (AREs) in promoter or enhancer regions of target genes. Subsequently, formation of an AR transcriptional complex occurs through recruitment of coactivators, basal transcription factors, mediator and RNA polymerase II. Coactivators comprise histone-modifying enzymes, chromatin-remodeling proteins and regulatory proteins that affect the AR itself (for review, see Heemers and Tindall 1 ). Thus, the transcriptional activity and specificity of the AR are regulated and modulated by posttranslational modifications, such as phosphorylation, acetylation, sumoylation and ubiquitination, 2 which influence the subcellular localization and stability of the AR, as well as assembly and activity of the transcription complex, by modulating AR/coactivator interactions. 1, 3 Extensive research, employing chromatin immunoprecipitation (ChIP), has revealed new and unexpected insights into the sequence of events, leading to transcriptional activation in vivo.
Mounting evidence points to a cyclic nature of nuclear receptor (NR)-dependent transcription, changing the view of a static association of NRs with their cognate sequences. 4, 5 As shown for the estrogen receptor (ER), transcription initiation is a highly dynamic process of transcription complex assembly that is coupled with chromatin modification and remodeling. [6] [7] [8] After transition to elongation, which is regulated by phosphorylation of the C-terminal domain of RNA polymerase II, the ER-transcription complex dissociates from regulatory elements (promoter clearance) to allow for a new round of initiation. For the AR, contradictory results have been reported. One study reported a continuous accumulation of AR at AREs of the PSA gene over 16 h, 9 whereas others demonstrated alternating cycles of association and dissociation of AR and its coregulators. [10] [11] [12] It is assumed that disassembly of NR transcription complexes is due to degradation of the NR itself. 6, 7 In line with this, recruitment of the S1 subunit of the 19S proteasome subcomplex and of E3 ligases to transcription complexes have been reported. 10, [13] [14] [15] In fact, there appears to be a tight coupling of NR-dependent transcription and proteasomal degradation as continued transcription depends on the activity of the proteasomal system and, in turn, degradation depends on transcription (for review, see Keppler et al. 13 ). Thus, these processes must be regulated by complex feedback mechanisms.
We have recently identified three novel coactivators of the AR, apoptosis-antagonizing transcription factor (AATF, also named Che-1), 16 tumor-susceptibility gene 101 (TSG101) 17 and zipperinteracting protein kinase (ZIPK, also termed Dlk, for DAP-like kinase, or DAPK3). 18 AATF was originally found as interaction partner of ZIPK. 19 It is involved in transcriptional regulation, cellcycle control, DNA-damage response and apoptosis (for review, see Passananti et al. 20 ) . A role as transcriptional coactivator for E2F, SP1 and AR has been clearly established. In the case of Rb/E2F and SP1, AATF can activate these transcription factors by releasing them from a repressive state through displacement of HDAC1. 21, 22 In the case of AR, AATF may have a role in assembly and stabilization of the AR-transcription complex.
18 TSG101 is an inactive ubiquitin conjugase and involved in different ubiquitinrelated processes such as intracellular protein sorting or virus budding (for references, see Burgdorf et al. 17 ). In our studies, TSG101 was recognized as interaction partner of AATF and as coactivator of AR. 17 According to our model, TSG101 enhances ARmediated transcription by transiently stabilizing the AR in a monoubiquitinated, presumably active state. 17 ZIPK is a serine/threonine-specific protein kinase involved in regulation of apoptosis, cell motility and contractility, as well as mitosis, particularly cytokinesis (for review, see Scheidtmann 23 ). Diminished expression or loss-of-function mutations are found in various types of cancers implicating a function as a tumor suppressor. [24] [25] [26] A role of ZIPK in transcription is supported from its interactions with transcription and splicing factors ATF4, AATF, STAT3 and CDC5. 19, [27] [28] [29] Recently, we identified ZIPK as novel interaction partner and coactivator of the AR. Coactivation of AR by ZIPK is dependent on the kinase activity of ZIPK but the substrate has not been identified yet. 18 The present study investigated a functional relationship between AR, AATF, TSG101 and ZIPK. ChIP analyses in combination with small interfering RNA (siRNA)-mediated knockdown revealed a cyclical association of AR and its coactivators with the PSA enhancer or promoter. Recruitment of AATF and ZIPK was dependent on AR, whereas recruitment of TSG101 was dependent on AATF. Interestingly, knockdown of ZIPK by siRNA had a similar effect as inhibition of the proteasome system, leading to reduced transcription but enhanced accumulation of AR at its AREs. Moreover, knockdown of ZIPK diminished polyubiquitination of AR. ZIPK cooperated with the E3 ligase Mdm2 in AR-dependent transactivation and phosphorylated Mdm2 in vitro. Thus, ZIPK has a crucial role in regulation of AR ubiquitination, thereby contributing to the cyclic transactivation of androgen-responsive genes.
RESULTS

Association of AR and its coactivators with regulatory elements occurs in cycles
Recognition of AATF, TSG101 and ZIPK as coactivators of the AR was mainly based on transient transactivation assays using ARresponsive reporter constructs and expression plasmids for rodent AATF, TSG101 and ZIPK. [16] [17] [18] In this study, we first corroborated these data for the endogenous human proteins, as well as for endogenous AR-target genes. The siRNA-mediated knockdown of AATF, TSG101 or ZIPK resulted in 20-40% reduction of PSA and KLK2 mRNA expression (Supplementary Figure S1) , thus confirming these proteins as bona fide coactivators of AR.
Next, we investigated the time course of assembly of AR and the three coactivators at regulatory elements of target genes using ChIP analyses. Samples were taken at 15-min intervals over 165 min upon dihydrostestosterone (DHT) treatment. As shown in Figures 1a and c, assembly of AR at the PSA enhancer and promoter occurred in cycles of association and dissociation. At the enhancer, the first cycle comprises the first 90 min after induction, whereas the second extends beyond the time span of 165 min explored here. For the promoter, a shorter first cycle within B45 min of induction and a second one between 60 and 150 min can be defined. For both elements association of AR was stronger in the second than in the first cycle. This cyclic behavior was even more pronounced for the coactivators. Assembly of ZIPK, TSG101 and AATF was detectable after 15 min in parallel with the AR, but afterwards shorter cycles were observed that seemed to be independent of the AR. A striking finding was the missing association of AATF and TSG101 upon 90 min of hormone stimulation correlating with the end of the first cycle at the PSA enhancer. Our data are in agreement with previous studies, 10, 12 pointing to a cyclic assembly of AR-transcription complexes.
To demonstrate that AR and the three coactivators are part of the same transcription complex on the PSA enhancer and promoter, serial ChIP experiments (ReChIPs) were performed. Chromatin was isolated at 45 or 95 min after hormone induction and sequentially precipitated first with anti-AR antibodies, eluted and then reimmunoprecipitated with antibodies against ZIPK, AATF or TSG101, or unspecific IgGs as negative control. Results shown in Figure 1d demonstrate that by 45 min, all three coactivators were present in the complexes originally precipitated with the AR. Interestingly, upon 95 min of DHT treatment on the PSA enhancer, the composition of the complexes changed in that association of AATF and TSG101 was reduced, confirming the results observed in the 15-min time course experiment. Likewise, ReChIPs after 75 min DHT treatment with anti-AATF or anti-TSG101 antibodies in the first IP, and antibodies against AR, ZIPK and TSG101 or AATF, respectively in the second IP, revealed principally the same results, thus corroborating the assembly of all investigated proteins in a single joint complex on chromatin (Figure 1e ).
Interdependence of coactivators Next, we investigated the interdependence of the coactivators in transcription complexes assembly. The siRNA-mediated knockdown of ZIPK (Figure 2a) , as validated by reverse transcription PCR for ZIPK mRNA and by ChIP for recruitment onto the PSA enhancer, revealed no significant effect on association of AATF, suggesting that its recruitment is independent from ZIPK. However, association of AR and TSG101 was enhanced compared with cells treated with control siRNA. Similar results were obtained for the PSA promoter (data not shown). To analyze whether ZIPK knockdown affects cycling of AR ChIP analysis with additional time points of DHT treatment covering the first and second AR cycle was conducted. Moreover, two separate siRNA sequences instead of the pool were transfected to rule out off target effects ( Figure 2b ). AR accumulated at 90 min as in Figure 2a and also during the second cycle on the PSA enhancer with both siRNA sequences causing approximately identical results. Knockdown of AATF (Figure 2c ), as confirmed by western blot (WB) analysis, resulted in a weaker association of AR and ZIPK but a strong reduction of TSG101. Thus, recruitment of TSG101 is dependent on AATF, whereas recruitment of ZIPK is not. However, AATF may have a stabilizing function for AR and ZIPK, as concluded previously ( Figure 2 ). 18 Degradation of AR is necessary for cyclic transcription complex assembly To elucidate the mechanism underlying the cyclic association of AR with regulatory elements, we performed transactivation assays, mRNA expression analyses of AR-target genes and ChIP analyses upon inhibition of the proteasome system by MG132. LNCaP cells pretreated with different concentrations of MG132 and afterwards stimulated with DHT showed that 10 mM MG132 are sufficient to block AR-dependent transactivation of reporter constructs (Figure 3a) , as well as endogenous PSA-, KLK2-and TMPRSS2 mRNA expression (Figure 3d ). This block was not due to side effects of MG132 on overall protein levels of AR, AATF, ZIPK or TSG101, as confirmed by WB analyses (Figure 3b ). However, ChIP analyses revealed a 1.7-fold or even 4.6-fold accumulation of AR at PSA enhancer or promoter elements, respectively, upon inhibitor treatment ( Figure 3c ). In contrast, all coactivators showed reduced recruitment. These results indicate that accumulated AR is transcriptionally inactive and, in turn, that efficient AR-mediated transcription is dependent on degradation of AR in agreement with published data (Figure 3 ). 7, 10 Cooperation between ZIPK and the E3 ligase Mdm2 in AR-dependent transactivation Interestingly, knockdown of ZIPK had a similar effect as the proteasome inhibitor MG132, leading to accumulation of AR on PSA regulatory elements (see above, Figure 3 ). This led us to investigate a possible involvement of ZIPK in regulation of ubiquitination and degradation of AR. One possibility was that ZIPK causes the release of TSG101 from the complex, thereby lifting the protection of monoubiquitinated AR and rendering it accessible for polyubiquitination. 17 Indeed, TSG101 accumulated at enhancer and promoter elements upon knockdown of ZIPK (see Figure 2a) . However, because TSG101 was not phosphorylated by ZIPK in vitro (data not shown), we did not pursue this possibility further. Rather, we considered a functional relationship with the E3 ligase Mdm2, first, because of its interaction with AATF and TSG101, 30, 31 second, for its contribution to AR ubiquitination 32 and third, because Mdm2 was described as potential substrate of ZIPK, because Mdm2-derived synthetic peptides were phosphorylated in vitro. 33 A possible interplay of ZIPK and Mdm2 in AR-dependent transcription was first investigated with reporter constructs.
Indeed, Mdm2 enhanced AR-mediated transactivation in a doseand hormone-dependent manner (Figure 4a ). WB analysis served as proof of equal protein levels with increasing amounts of expressed Mdm2. This is at variance to a previous report showing a repressing effect of Mdm2 on AR-mediated transcription, 14 but in agreement with 34 who reported a coactivating effect of Mdm2 on ER. Coexpression of ZIPK and Mdm2 further enhanced luciferase activity more than additive, suggesting a cooperative effect of both proteins. Strikingly, the coactivating effect of Mdm2 was counteracted by coexpression of Mdm2 with the kinase-dead mutant ZIPKD161A. These data suggest that the coactivating effect of Mdm2 is dependent on phosphorylation by ZIPK. Indeed, Mdm2 was phosphorylated by ZIPK in vitro (unpublished data) in agreement with a previous report. 33 Furthermore, both proteins assembled into a single complex on chromatin as revealed by ReChIP (Figure 4c ). Interestingly, this occurred at 45 min on the PSA promoter and at 90 min on the PSA enhancer to the respective end of the first AR cycle (Figure 4 ).
ZIPK affects AR ubiquitination state
To investigate whether ZIPK contributes to degradation of AR by regulating its ubiquitination status, we performed in vivo ubiquitination assays. HEK293 cells were transfected with His-Ubiquitin and expression plasmids for AR, ZIPK, mutant ZIPKD161A, Mdm2, TSG101 or AATF in the presence of MG132 to minimize intracellular protein degradation. Extracts were prepared under denaturing conditions and subjected either to nickel-nitrilotriacetic acid (Ni-NTA) affinity purification followed by WB or directly to WB analysis. Results are shown in Figure 5a . The upper panels show mono-and polyubiquitinated forms of AR. The patterns obtained upon Ni-NTA affinity purification are almost identical to those obtained with raw extracts, indicating that purification of the different forms is rather effective and representative. In the absence of His-Ub, only a faint background band of monoubiquitinated AR was detected upon affinity purification (see Figure 5a , lower left panel), whereas in the extract a strong band was seen, indicating that AR becomes ubiquitinated by endogenous ubiquitin and demonstrating the specificity of the assay.
In the absence of hormone, mainly monoubiquitinated AR (the fastest migrating form) was seen, whereas polyubiquitinated AR was hardly detectible. Upon DHT treatment, the amount of monoubiquitinated increased and some polyubiquitinated AR appeared. Coexpression of Mdm2 strongly enhanced polyubiquitination of AR, as expected. Likewise, coexpression of AATF and, to lesser extent, ZIPK enhanced polyubiquitination. Coexpression of TSG101 increased the amount of monoubiquitinated AR, in agreement with our previous observations, 17 but polyubiquitinated AR was also seen. Strikingly, the kinase-dead ZIPK mutant seemed to interfere with polyubiquitination down to the level of uninduced cells, as observed in the Ni-NTA eluate as well as in cell extracts. Particularly, this latter result supports our assumption that ZIPK is involved in regulation of ubiquitination.
To further elucidate a role for ZIPK in AR ubiquitination, ZIPK was depleted by siRNA and the ubiquitination state of AR was determined. Indeed, knockdown of ZIPK, as confirmed by reverse transcription PCR (Figure 5c ), resulted in strong reduction of mono-and, especially, polyubiquitinated AR. In contrast, cells treated with control siRNA showed a hormone-dependent AR ubiquitination as before (Figure 5b) . In order to control for a general effect of ZIPK knockdown on ubiquitination, the membrane of the Ni-NTA eluates was reprobed with anti-ubiquitin antibodies. As shown in Figure 5d , loss of endogenous ZIPK appeared to reduce the fraction of His-ubiquitinated proteins in general. To strengthen the function of ZIPK in AR polyubiquitination, we generated siRNA-resistant Flag-ZIPK and Flag-ZIPKD161A expression constructs. The introduced mutations were verified by sequencing and the siRNA resistance by analyzing protein and mRNA expression after siRNA treatment against ZIPK (Figure 5e ). The reintroduction of ZIPK rescued AR polyubiquitination of ZIPKdepleted cells, whereas the reintroduction of the kinase-dead mutant did not rescue the effect on AR ubiquitination. Altogether, our results show that ZIPK participates in regulation of ubiquitination of AR and, presumably, other proteins ( Figure 5 ).
DISCUSSION
Genetic alterations causing dysregulations in AR-dependent transcription contribute to the development of prostate cancer. Therefore, detailed knowledge of how the activity of AR is regulated and how the diverse coregulators influence this activity are prerequisite to develop anti-cancer strategies and therapies. In this study, we confirmed the coactivator functions of human ZIPK, AATF and TSG101 through mRNA expression analyses of AR-target genes and recruitment onto AREs. We show a cyclical association of AR and its coactivators with cognate sequences, and particularly for ZIPK, a role in regulation of AR ubiquitination.
The three coactivators were originally identified by interaction screening, AATF as interaction partner of ZIPK 19 and TSG101 as interaction partner of AATF. 17 Therefore, it was conceivable that the three proteins form a structural and functional subcomplex within the AR-coactivator complex. Results from ChIP and ReChIP analyses indicate that all three are indeed present in the same complex. Of the three proteins, AATF and ZIPK appear to be recruited onto the activated AR directly and independently of each other, as revealed by ChIP analyses after siRNA-mediated knockdown. AATF contains three LXXLL motifs, which facilitate interaction with AR. 16 In addition, AATF and ZIPK interact with each other via their leucine zippers, thereby stabilizing the AR-ZIPK complex. 18 In contrast, recruitment of TSG101 was dependent on AATF. Thus, AATF has a targeting function for TSG101 and a stabilizing function for AR-ZIPK interaction.
The discrepancy between continuous 9 versus cyclic association [10] [11] [12] of AR-transcription complexes with chromatin was clearly resolved in favor of the latter as revealed by ChIP analyses at short time intervals upon hormone stimulation. Assembly of AR and coactivators onto regulatory elements was highly dynamic and occurred in a cyclic fashion. For the association of AR with the PSA-enhancer cycles of 90 min and for the PSA promoter, a shorter first cycle of 30 min and a second cycle of about 90 min could be defined, with a stronger association during the second cycle. These findings agree well with earlier studies. [10] [11] [12] The shortened cycle of AR at the PSA promoter corresponds to a shortened cycle of ER at the pS2 promoter 8 proposed to serve in recruitment of chromatin-remodeling complexes and thus to prepare the promoter for transcription initiation. 7 Consequently, the initial opening of chromatin structure maintained by histone modifications facilitates easier access in following rounds of assembly. 6, 10 In summary, cyclic recruitment of NRs, such as AR, ER, TR and VDR, 10, 6, 35, 36 is thought to provide a means of rapid response to changes in the level of their cognate ligands or environmental or cell-cycle conditions. Interestingly, the coactivators AATF, ZIPK and TSG101 followed the pattern of AR only for the first round of association. After that, they exhibited shorter association/dissociation cycles. Thus, AR, and perhaps other coactivators like SRC-1 and CBP/p300, may serve as a platform onto which AATF, ZIPK, TSG101 and others assemble and disassemble.
Association/dissociation cycles are due to proteasomal degradation as revealed by inhibiting the proteasome system with MG132, leading to accumulation of AR at promoter/enhancer elements. On the other hand, AR-mediated transcription was reduced under these conditions, indicating that accumulated AR is transcriptionally incompetent. Thus, the initial transcription complex allows only for limited rounds of transcription, and dissociation or degradation of AR from the promoter, also termed promoter clearance, and reassembly of new AR-transcription complexes are required for efficient transcription to continue. These results agree well with earlier studies, which pointed out a tight coupling of transcription and degradation. 6, 10, 32, 37 Again, the coactivators behaved differently in that they were reduced both at the promoter and enhancer, again demonstrating that their association/dissociation is regulated independently of AR. Perhaps, the accumulated AR or the coactivators undergo posttranslational modifications that facilitate dissociation but prevent reassociation.
Unexpectedly, knockdown of ZIPK leads to accumulation of AR at promoter/enhancer elements to similar extent as inhibition of the proteasome system strongly, suggesting that ZIPK is involved in regulation of degradation, presumably by regulating ubiquitination of AR. Indeed, ectopic expression of ZIPK enhanced polyubiquitination of AR. Moreover, knockdown of ZIPK or expression of dominant-negative mutant ZIPKD161A strongly reduced AR polyubiquitination, which could be rescued by siRNAresistant ZIPK. These results strengthen a function of ZIPK in regulation of AR ubiquitination. We speculated that this function might be mediated by interaction with Mdm2, because Mdm2 was reported to be a potential substrate of ZIPK, 33 and because Mdm2 was shown to be involved in ubiquitination and degradation of AR. 32 Indeed, Mdm2 was phosphorylated by ZIPK in vitro, and both proteins cooperated in AR-dependent reporter gene expression in a kinase-dependent manner. As the coactivating function of ZIPK is strictly dependent on its kinase activity (18; this study) and neither AR nor other coactivators, SRC-1 and SRC-3, were phosphorylated by ZIPK, in vitro (18; Felten unpublished results), it is likely that Mdm2 is the relevant substrate of ZIPK, in vivo, within the active transcription complex where both could be detected assembled into a single complex.
Interestingly, AATF and TSG101 seem also to be involved in regulation of ubiquitination of the AR, TSG101 by protecting AR in its monoubiquitinated state 17 and AATF by recruiting TSG101 (this study). Accordingly, AATF knockdown causes weaker association of AR at regulatory elements maybe because of faster accessibility for polyubiquitination and degradation. 17 However, overexpression of AATF strongly enhanced polyubiquitination of AR, which appears to counteract the activity of TSG101. In fact, AATF can also interact with Mdm2 as was shown for p53-mediated apoptosis 30 and this interaction might apply for AR, too. We propose that AATF may serve as an exchange factor mediating the exchange of TSG101 for Mdm2 and thereby the switch from mono-to polyubiquitination and consequently degradation of the AR. As pointed out above, degradation of AR is dependent on successful transcription. 13 Thus, the event mediating the transition from transcription initiation to elongation might also initiate degradation of AR. Elongation is initiated by phosphorylation of RNA polymerase II through Cdk7. Strikingly, the same kinase phosphorylates the AR resulting in recruitment of Mdm2 and degradation of AR. 38 Interestingly, ZIPK contains also a Cdk phosphorylation site (KH Scheidtmann, unpublished data). Phosphorylation of this site contributes to activation of ZIPK. 39 It is conceivable that phosphorylation of ZIPK by Cdk7 serves as the signal for Mdm2 phosphorylation. Thus, Cdk7 might be the key regulator, which links transcription and degradation.
ZIPK has also a tumor-suppressor function, which is presumably mediated through its pro-apoptotic activity. Epigenetic silencing, loss-of-function or dominant-negative mutations, such as D161N, have been detected in a number of tumors and are associated with loss of growth inhibition, increased cell proliferation, invasion and/or metastasis. [24] [25] [26] Whether loss-of-function mutations of ZIPK contribute to prostate cancer development remains to be investigated. Primary prostate carcinomas are strictly hormone, that is, AR-dependent and undergo apoptosis in their absence. It is tempting to speculate that ZIPK provides a sensor that monitors the state of AR and induces apoptosis in absence of AR activity. Loss of ZIPK activity would render the tumor AR independent.
MATERIALS AND METHODS
Cell culture HEK293 cells were maintained in Dulbecco's modified Eagle medium (Sigma-Aldrich, Taufkirchen, Germany) supplemented with 10% fetal bovine serum (Biochrom Seromed, Berlin, Germany). LNCaP cells (human prostate carcinoma) were grown in Roswell Park Memorial Institute medium containing 15% fetal bovine serum and 1% glutamine. Experiments involving hormone induction were performed in so called 'starved' cells grown in hormone-depleted medium (phenol red-free Roswell Park Memorial Institute medium containing 5% charcoal-stripped fetal bovine serum (PAN-Biotech, Aidenbach, Germany) 3 days before and during the experiment.
Plasmids and transfection
The origin of expression plasmids encoding human AR, AATF/Che-1, TSG101 and His-Ub has been described; 16, 17 pCMV-Mdm2 was kindly provided by Moshe Oren (Rehovot, Israel). Reporter plasmids included MMTV-Luc 16 and pRL-CMV (Promega, Mannheim, Germany). cDNA coding for human ZIPK was isolated from MCF7 cells by reverse transcription PCR and cloned into pDRIVE vector (Qiagen, Hilden, Germany) using the following primers: forward: 5 0 -ATGTCCACGTTCAGGCAGGAGGACG-3 0 and reverse: 5 0 -CTAGCGCAGCCCGCACTCCACGCCC-3 0 . Subcloning into human expression plasmids resulted in GFP-ZIPK and Flag-ZIPK. For kinase-dead mutant ZIPKD161A, aspartic-acid residue 161 was replaced by alanine using the QuickChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA). Because of subcloning, Flag-ZIPK and Flag-ZIPKD161A differ in their molecular weights. For siRNA-resistant Flag-ZIPK and Flag-ZIPKD161A, primers containing 4-bp changes (forward: 5 0 -CGACTTCGACGAGGAATA CTTTTCCAACACCAGCGAGC-3 0 ; reverse: 5 0 -GCTCGCTGGTGTTGGAAAAGTAT TCCTCGTCGAAGTCG-3 0 ) and the QuickChange Site-Directed Mutagenesis Kit were used. Transfections were carried out using Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany).
Antibodies and chemical reagents
Antibodies against AR (H-280), Mdm2 (HDM2-323), Par-4 (R-334), TSG101 (C-2), Ubiquitin (FL-76) and unspecific mouse and rabbit IgGs were purchased from Santa Cruz Biotechnology (Heidelberg, Germany). Antibodies against AATF (M09) were from Abnova (Heidelberg, Germany); Flag-M2 and alpha-Tubulin from Sigma-Aldrich; ZIPK (279-298) from Calbiochem (Darmstadt, Germany); and Multi-Ubiquitin (FK2) from Assay Designs (Lö rrach, Germany). 5a-dihydrotestosterone (DHT) and carbobenzoxy-L-leucyl-L-leucinal (MG132) were purchased from Sigma-Aldrich.
Transactivation assays
Transactivation assays were performed as described using firefly luciferase reporter constructs. 40 For normalization, Renilla luciferase activity was determined in buffer containing 25 mM Tris-HCl pH 7.5, 0.1 M NaCl, 1 mM CaCl 2 and 0.9 mM coelenterazin. Data shown are relative values of Firefly luciferase normalized to Renilla luciferase representing mean relative luciferase activity±s.d. Transactivation experiments were performed in triplicate and repeated three times.
SiRNA, total RNA isolation, reverse transcription and semiquantitative PCR Starved LNCaP were transfected with 100 mM siRNA (Dharmacon, Lafayette, CO, USA) against human ZIPK, AATF (Che-1: 5 0 -UGGCUUGCAAUCCAGAA-GUUACGUU-3 0 kindly provided by Dr M Fanciulli), TSG101, Par-4 or control (random) siRNA and treated with ± 100 nM DHT as indicated. RNA was isolated with TRIzol (Invitrogen) and subjected to reverse transcriptase PCR with SuperScript III (Invitrogen). The mRNA levels of AR-target genes or coactivators were quantified with EasyWin32 (Herolab, Wiesloch, Germany) and normalized against the glyceraldehyde-3-phosphate dehydrogenase mRNA after semiquantitative PCR. Primer sequences are listed in Supplementary Table S1 .
Chromatin immunoprecipitation
After respective pretreatments ChIP was carried out as previously described 18 with some modifications. Briefly, chromatin was cross-linked 10 min at room temperature with 1.4% paraformaldehyde. Fixation was stopped with ice-cold 125 mM glycine. Cells were rinsed twice with ice-cold PBS and resuspended in 1 ml IP-buffer (150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 20 mM Tris-HCl pH 8.0, 10 mM Na 2 MoO 4 and 1 Â complete proteaseinhibitor-mix (Roche, Mannheim, Germany)). Nuclei were pelleted by centrifugation (800 g, 41C, 2 min) and resuspended in 300 ml lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl pH 8.0, 10 mM Na 2 MoO 4 and 1 Â complete protease-inhibitor-mix). Chromatin was sonicated with a Branson sonicator microtip (Branson, New Brunswick, NJ, USA) on ice (6 Â 15 s, 40% output) to an average size of B750 bp. Insoluble material was removed by centrifugation (13.000 g, 41C, 10 min). A total of 150 mg of fragmented chromatin was diluted in 1 ml IP-buffer and incubated at 4 1C overnight with 0.5-1 mg of respective antibodies followed by adsorption to protein-A sepharose for 1 h. Unspecific binding was blocked by preincubating IPs and sepharose with single-stranded salmon sperm DNA. Immunoprecipitates were washed and eluted as described previously. Sequential ChIP analyses (ReChIP) were performed essentially as described. 18 Relative amounts of precipitated DNA fragments were determined by semiquantitative PCR, using GoTaq polymerase (Promega). Primer sequences are listed in Supplementary Table S1 .
In vivo ubiquitination of AR To allow isolation of ubiquitinated proteins under denaturing conditions, HEK293 cells were cotransfected with expression plasmids coding for ± 6 Â His-ubiquitin, Flag-AR and respective proteins or siRNA as indicated. After 24 h, fresh medium containing 2 mM MG132 and ± 100 nM DHT was supplied for another 16 h. Cell extracts were prepared by sonication (2 Â 15 s, 40% output) in 500 ml denaturing lysis buffer (8 M urea, 100 mM NaH 2 PO 4 , 10 mM Tris-HCl and 20 mM imidazole, pH 8.0). After centrifugation (13.000 g, 4 1C, 15 min), the cell lysate was incubated with Ni-NTA-agarose (Qiagen), which had been extensively washed and equilibrated with washing buffer (8 M urea, 100 mM NaH 2 PO 4 , 10 mM Tris-HCl and 20 mM imidazole, pH 6.2). After 2 h, the beads were rinsed three times with washing buffer, ubiquitinated proteins were eluted with 2 Â SDS sample buffer and analyzed by WB using anti-AR antibodies.
